Cytokine-induced depression during IFN-α treatment: The role of IL-6 and sleep quality
- 15 July 2009
- journal article
- Published by Elsevier in Brain, Behavior, and Immunity
- Vol. 23 (8), 1109-1116
- https://doi.org/10.1016/j.bbi.2009.07.001
Abstract
No abstract availableKeywords
This publication has 95 references indexed in Scilit:
- Poor sleep quality predicts onset of either major depression or subsyndromal depression with irritability during interferon-alpha treatmentPsychiatry Research, 2010
- Does cytokine-induced depression differ from idiopathic major depression in medically healthy individuals?Journal of Affective Disorders, 2009
- Activation of Central Nervous System Inflammatory Pathways by Interferon-Alpha: Relationship to Monoamines and DepressionBiological Psychiatry, 2008
- Risk for Depression During Interferon-Alpha Treatment Is Affected by the Serotonin Transporter PolymorphismBiological Psychiatry, 2008
- Interferon-α effects on diurnal hypothalamic–pituitary–adrenal axis activity: relationship with proinflammatory cytokines and behaviorMolecular Psychiatry, 2008
- Functional polymorphisms in the interleukin-6 and serotonin transporter genes, and depression and fatigue induced by interferon-α and ribavirin treatmentMolecular Psychiatry, 2008
- Self-reported symptoms of sleep disturbance and inflammation, coagulation, insulin resistance and psychosocial distress: Evidence for gender disparityBrain, Behavior, and Immunity, 2008
- From inflammation to sickness and depression: when the immune system subjugates the brainNature Reviews Neuroscience, 2008
- Cytokine-effects on glucocorticoid receptor function: Relevance to glucocorticoid resistance and the pathophysiology and treatment of major depressionBrain, Behavior, and Immunity, 2006
- Cytokine Production and Treatment Response in Major Depressive DisorderNeuropsychopharmacology, 2000